Voyager Therapeutics Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
32.44 M |
Public Float |
18.44 M |
Voyager Therapeutics Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$2.94 |
Market Cap |
$1.01 B |
Shares Outstanding |
36.83 M |
Public Float |
20.17 M |
Address |
75 Sidney Street Cambridge Massachusetts 02139 United States |
Employees | - |
Website | http://www.voyagertherapeutics.com |
Updated | 07/08/2019 |
Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which develops treatments for patients suffering from central nervous system. Its pipeline of gene theraphy programs include VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guangping Gao, Mark A. |